Logos Global Management »

Engene Holdings shares owned by Logos Global Management

Quarter-by-quarter ownership of Engene Holdings (ENGN) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $13M 800k 16.10

More positions owned by Logos Global Management

Sarepta Therapeutics (SRPT)
Alnylam Pharmaceuticals Call Option (ALNY)
Ideaya Biosciences (IDYA)
Immunocore Hldgs Ads (IMCR)
Immunovant (IMVT)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Olema Pharmaceuticals (OLMA)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Rocket Pharmaceuticals (RCKT)
Astria Therapeutics Call Option (ATXS)
Silence Therapeutics Ads (SLN)
Geron Corporation (GERN)
Annexon (ANNX)

View all positions for Logos Global Management

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
VR Adviser
Blue Owl Capital Holdings
BVF
Deep Track Capital
Commodore Capital
Adage Capital Partners GP
Omega Fund Management
Cormorant Asset Management
Henderson Group
Perceptive Advisors
Citadel Advisors
Deerfield Management Company
Logos Global Management
Soleus Capital Management

View all funds holding Engene Holdings